SafetyEasyAB Cube
|
VigilanceVigilance Fintech Software
|
|||||
Related Products
|
||||||
About
Efficient drug safety operations with the technological expertise of industry veterans begins here.
Align international pharmacovigilance operations teams with an intuitive, unified, cloud-based safety system trusted by industry leaders. SafetyEasy® Suite is a multivigilance management solution which integrates automation with existing drug safety processes.
Growing biotechnology firms trust individual vigilances provided by AB Cube for their safety regulatory processes. Life sciences organisations manage adverse event reporting and stay compliant with the latest regulations with SafetyEasy® Suite.
SafetyEasy® Suite is AB Cube’s all-in-one ecosystem for automated multivigilance management. Built to make safety simple, scalable, and smart. Designed for organizations of all sizes, it’s a modular, cloud-based platform that automates every step of the vigilance process, from early stage data capture to regulatory reporting and advanced analytics.
Flexible and compliant by design,
|
About
VigilanceAML is an online software, trusted by businesses of all sizes across New Zealand to comply with the complex anti-money-laundering standards. CDD processes vary depending on your customer type, face-to-face and offshore clients, Trust etc. VigilanceAML provides all the tools you need to onboard your customer efficiently. Have your customers fill out a secure online form, upload necessary documents all of which get attached to your client record saving data entry time and using unsecured emails. ODD is equally important to remain compliant. VigilanceAML provides smart features to streamline ODD and keep you up to date. VigilanceAML can analyze any Trust account statements for you, setup rules and help filter out risk of missing PTR’s. Direct integration to ASB included. VigilanceAML integration to GoAML will save you hours of frustration by automating the proceeds avoiding manual data entry.
|
|||||
Platforms Supported
Windows
Not Supported
Mac
Not Supported
Linux
Not Supported
Cloud
Supported
On-Premises
Not Supported
iPhone
Not Supported
iPad
Not Supported
Android
Not Supported
Chromebook
Not Supported
|
Platforms Supported
Windows
Not Supported
Mac
Not Supported
Linux
Not Supported
Cloud
Supported
On-Premises
Not Supported
iPhone
Not Supported
iPad
Not Supported
Android
Not Supported
Chromebook
Not Supported
|
|||||
Audience
Life sciences organizations wanting a solution to manage increasing volumes of safety cases and regulatory requirements in pharmacovigilance and related fields
|
Audience
Lawyers and accountants searching for an AML software
|
|||||
Support
Phone Support
Supported
24/7 Live Support
Not Supported
Online
Supported
|
Support
Phone Support
Supported
24/7 Live Support
Not Supported
Online
Supported
|
|||||
API
Offers API
Supported
|
API
Offers API
Not Supported
|
|||||
Screenshots and Videos |
Screenshots and Videos |
|||||
PricingBuilt for All Sizes and Needs
Only Pay for What You Pick. No Hidden Fees
Free Version
Not Supported
Free Trial
Supported
|
Pricing
$165 per month
Free Version
Not Supported
Free Trial
Not Supported
|
|||||
Reviews/
|
Reviews/
|
|||||
Training
Documentation
Supported
Webinars
Supported
Live Online
Supported
In Person
Supported
|
Training
Documentation
Not Supported
Webinars
Supported
Live Online
Supported
In Person
Not Supported
|
|||||
Company InformationAB Cube
Founded: 2006
France
www.ab-cube.com/vigilance/
|
Company InformationVigilance Fintech Software
Founded: 2015
New Zealand
www.vigilance.co.nz
|
|||||
Alternatives |
Alternatives |
|||||
|
|
|
|||||
|
|
|
|||||
|
|
|
|||||
|
|
||||||
Categories |
Categories |
|||||
Fraud Detection Features
Access Security Management
Not Supported
Check Fraud Monitoring
Supported
Custom Fraud Parameters
Supported
For Banking
Not Supported
For Crypto
Not Supported
For eCommerce
Not Supported
For Insurance Industry
Not Supported
Internal Fraud Monitoring
Supported
Investigator Notes
Not Supported
Pattern Recognition
Supported
Transaction Approval
Not Supported
|
||||||
|
|
|